Our mission at Talee Bio is to change the course of cystic fibrosis and other genetic lung diseases by developing novel genetic treatments. Our gene therapy technologies are designed to overcome the barriers that have so far prevented effective genetic treatments for cystic fibrosis.
Talee Bio has two gene therapy product candidates to treat cystic fibrosis. The major hurdles of gene therapy for cystic fibrosis are poor efficacy (i.e., transduction efficiency, expression persistence, packaging capacity, avoidance of immunogenicity), low safety and tolerability (including genotoxicity for those vectors that result in genomic integration), and inability to manufacture sufficient vector. Our proprietary platform technologies and our product candidates are designed to address all of these deficiencies.
Company Details
- Founded
- -
- Address
- 3001 Market Street, Suite 140, Philadelphia,pa 19104,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://taleebio.com/
- Keywords
- biotechnology, gene therapy, cystic fibrosis.
- HQ
- Philadelphia, PA
Talee Bio Questions
Talee Bio's website is http://taleebio.com/
Talee Bio's LinkedIn profile is https://www.linkedin.com/company/talee-bio
Talee Bio's industry is
Biotechnology Research
Talee Bio's top competitors are
Kh Supply Chain Llc,
Gene Therapy Program | University Of Pennsylvania,
Bioanalysis, Llc,
Invent Medical,
Center For Cellular Immunotherapies @ Upenn,
Volta Therapeutics,
Seneca Therapeutics, Inc.,
Limelight Bio,
Sbarro Health Research Organization,
Ciscovery Bio Inc.
Talee Bio's categories are Biotechnology Research
Talee Bio's founding year is 2016
